Genome Edited Cell Line Service

The CRISPR-Cas9 system enables highly efficient gene editing—such as knock-out and knock-in—by recognizing and cutting target DNA sequences through the complex of sgRNA and the Cas9 protein. ToolGen, a leading company in CRISPR-Cas9–based gene editing technology, has accumulated extensive experience and expertise in developing gene-editing therapeutics. Building on this foundation, ToolGen offers customized genome-edited cell line production services to meet diverse client needs.

Overview

Advantages of ToolGen's Genome Edited Cell Line Production Service

Customized Production

  • Optimized sgRNA selection and cell line engineering through pre-consultation to meet the client’s specific objectives.  
  • Provides tailored strategies for cell lines that are difficult to edit, ensuring successful genome modification.  

High-Efficiency Editing

  • Mixed Cell Pool Service: Provides pools with up to 60% In/Del efficiency.  
  • Single Cell Clone Service: Enables selection of clones with 100% In/Del efficiency.  
  • Utilizes highly specific sgRNA and transfection with Cas9 protein (RNP) or mRNA to minimize off-target effects.  

Various Applications

  • Gene function research
  • Customized disease model cell production
  • Cell and gene therapy research and development  

Workflow

workflow

Pre-Selected sgRNA

ServiceItem DescriptionsPeriod
Knock-Out Cell Line Service Mixed Cell pool 3-5 week
Single Cell Clone 6-8 week
Knock-In Cell Line Service Mixed Cell pool 8-10 week
Single Cell Clone 11-13 week

Novel sgRNA Screening

ServiceItem DescriptionsPeriod
Knock-Out Cell Line Service Mixed Cell pool 5-7 week
Single Cell Clone 8-10 week
Knock-In Cell Line Service Mixed Cell pool 10-12 week
Single Cell Clone 13-15 week

Optional QC Service

AssayMethods
Expression testsRT-qPCR, WB, FACS
Chromosome analysisKaryotyping
Off-target analysis

Contact Information

사업개발실

조성희 과장

E-mail: bd@toolgen.com

Tel: +82 2 3660-1320

치료제연구소

이강인 수석연구원

E-mail: ki.lee@toolgen.com

Tel: +82 2 3660-1363